Use the Back button in your browser to see the other results of your search or to select another record.
| High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial [with consumer summary] |
| Basu J, Nikoletou D, Miles C, MacLachlan H, Parry-Williams G, Tilby-Jones F, Bulleros P, Fanton Z, Baker C, Purcell S, Lech C, Chapman T, Sage P, Wahid S, Sheikh N, Jayakumar S, Malhotra A, Keteepe-Arachi T, Gray B, Finocchiaro G, Carr-White G, Behr E, Tome M, O'Driscoll J, Chis Ster I, Sharma S, Papadakis M |
| European Heart Journal 2025 May;46(19):1803-1815 |
| clinical trial |
| This trial has not yet been rated. |
|
BACKGROUND AND AIMS: The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise programme and explore safety and efficacy outcomes in patients with HCM. METHODS: Participants were randomized to a 12-week supervised exercise programme (n = 40) in addition to usual care, or usual care alone (n = 40). All participants underwent assessment at baseline and 12 weeks. The exercise group was re-evaluated 6 months post-programme. Feasibility was assessed by (i) recruitment, adherence, and retention rates; (ii) staffing ratios; (iii) logistics; and (iv) acceptability of the intervention. The primary exploratory safety outcome was a composite of arrhythmia-related events. Exploratory secondary outcomes included changes in (i) cardiorespiratory fitness; (ii) cardiovascular risk factors; and (iii) quality of life, anxiety, and depression scores. RESULTS: Overall, 67 (84%) participants completed the study (n = 34 and n = 33 in the exercise and usual care groups, respectively). Reasons for non-adherence included travel, work, and family commitments. Resource provision complied with national cardiac rehabilitation standards. There was no difference between groups for the exploratory safety outcome (p = 0.99). At 12 weeks, the exercise group had a greater increase in peak oxygen consumption (VO2) (+4.1 mL/kg/min, 95% confidence interval (CI) 1.1, 7.1) and VO2 at anaerobic threshold (+2.3 mL/kg/min, 95% CI 0.4 to 4.1), lower systolic blood pressure (-7.3 mmHg, 95% CI -11.7 to -2.8) and body mass index (-0.8 kg/m2, 95% CI -1.1 to -0.4), and greater improvement in hospital anxiety (-3, 95% CI -4.3 to -1.7) and depression (-1.7, 95% CI -2.9 to -0.5) scores, compared to the usual care group. Most exercise gains dissipated at 6 months. CONCLUSIONS: A high intensity exercise programme is feasible in patients with HCM, with apparent cardiovascular and psychological benefits, and no increase in arrhythmias. A large-scale study is required to substantiate findings and assess long-term safety of high intensity exercise in HCM.
|